Asensus Surgical Inc. buy krebskrebs
Start price
17.05.21
/
50%
€1.42
Target price
17.05.22
€2.00
Performance (%)
-73.34%
End price
18.05.22
€0.38
Summary
This prediction ended on 18.05.22 with a price of €0.38. Massive losses of -73.34% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Asensus Surgical Inc. | - | - | - | - |
| iShares Core DAX® | 3,59 % | 6,43 % | 15,38 % | 52,31 % |
| iShares Nasdaq 100 | 5,81 % | 6,38 % | 41,46 % | 91,77 % |
| iShares Nikkei 225® | 4,08 % | 9,31 % | 48,95 % | 65,86 % |
| iShares S&P 500 | 4,14 % | 4,94 % | 31,59 % | 65,33 % |
Comments by krebskrebs for this prediction
In the thread Transenterix Inc diskutieren
In the thread Trading Transenterix Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten